| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Annals of Thoracic Surgery, Vol 49, 242-246, Copyright © 1990 by The Society of Thoracic Surgeons
P Thomas and L Rubinstein
The Lung Cancer Study Group entered 907 eligible patients with T1 N0
non-small cell lung cancer in one of three successive clinical trials. At
the time of analysis, 201 of these patients were free from malignancy 60
months after operation. Thirty percent of patients who died were free from
malignancy at death. Death rates were comparable for the total group (907
patients) and the patients free from malignancy at 60 months (201 patients)
(0.086 versus 0.079, respectively); therefore death was not a suitable
therapeutic end point. Cancer recurrences were more frequent in patients
with non- squamous carcinoma than those with squamous carcinoma (0.088
versus 0.042); however, this difference was not observed after a 60-month
malignancy-free interval (0.035 versus 0.022, respectively). Select
comparisons between the total group of 907 patients and the 201 patients
free from malignancy at 60 months are noteworthy: (1) the rate of
occurrence of new, nonpulmonary malignancies was constant (0.016 versus
0.018, respectively); (2) the rate of pulmonary recurrences decreased
(0.043 versus 0.013, respectively); and (3) the rate of occurrence of new
lung cancer increased (0.009 versus 0.016, respectively). Therefore,
although cancer recurrences decreased with survival, new lung cancer
occurrences increased, and the probability of malignant disease appearing
more than 60 months after operation for T1 N0 non-small cell lung cancer
dictates continued patient surveillance.
ARTICLES
Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group [published erratum appears in Ann Thorac Surg 1991 Mar;51(3):526]
Information Management Services, Inc., Rockville, MD 20852.
This article has been cited by other articles:
|
|
 |
|
  M. J. Schuchert, B. L. Pettiford, A. Pennathur, G. Abbas, O. Awais, J. Close, A. Kilic, R. Jack, J. R. Landreneau, J. P. Landreneau, et al. Anatomic segmentectomy for stage I non-small-cell lung cancer: Comparison of video-assisted thoracic surgery versus open approach. J. Thorac. Cardiovasc. Surg., December 1, 2009; 138(6): 1318 - 1325.e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Detterbeck Critical Points When Using Vectors J. Clin. Oncol., October 20, 2009; 27(30): e166 - e166. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kreuter, M. Kropff, A. Fischaleck, K. Junker, J. Gerss, A. Heinecke, M. Lindermann, N. Reinmuth, W. E. Berdel, R. M. Mesters, et al. Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Eur. Respir. J., June 1, 2009; 33(6): 1383 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, and K. Kameyama Postrecurrence survival in patients with stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bordoni Consensus Conference: Multimodality Management of Early- and Intermediate-Stage Non-Small Cell Lung Cancer Oncologist, September 1, 2008; 13(9): 945 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Azouz, J. Walpole, S. Amirifeli, K. N. Taylor, M. W. Grinstaff, and Y. L. Colson Prevention of local tumor growth with paclitaxel-loaded microspheres. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1014 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. El-Sherif, W. E. Gooding, R. Santos, B. Pettiford, P. F. Ferson, H. C. Fernando, S. J. Urda, J. D. Luketich, and R. J. Landreneau Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer: A 13-Year Analysis Ann. Thorac. Surg., August 1, 2006; 82(2): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Kim, J. W. Kim, J. Han, Y. M. Shim, J. Park, and D.-H. Kim Cohypermethylation of p16 and FHIT Promoters as a Prognostic Factor of Recurrence in Surgically Resected Stage I Non-Small Cell Lung Cancer. Cancer Res., April 15, 2006; 66(8): 4049 - 4054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Meyers, F. Haddad, B. A. Siegel, J. B. Zoole, R. J. Battafarano, N. Veeramachaneni, J. D. Cooper, and G. A. Patterson Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S.A. Qadri, J.-H. Wang, J.C. Coffey, M. Alam, A. O'Donnell, T. Aherne, and H. P. Redmond Can Surgery for Cancer Accelerate the Progression of Secondary Tumors Within Residual Minimal Disease at Both Local and Systemic Levels? Ann. Thorac. Surg., September 1, 2005; 80(3): 1046 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tsurutani, S.S. Castillo, J. Brognard, C. A. Granville, C. Zhang, J. J. Gills, J. Sayyah, and P. A. Dennis Tobacco components stimulate Akt-dependent proliferation and NF{kappa}B-dependent survival in lung cancer cells Carcinogenesis, July 1, 2005; 26(7): 1182 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S.A. Qadri, J.-H. Wang, J. C. Coffey, M. Alam, A. O'Donnell, T. Aherne, and H. P. Redmond Surgically Induced Accelerated Local and Distant Tumor Growth is Significantly Attenuated by Selective COX-2 Inhibition Ann. Thorac. Surg., March 1, 2005; 79(3): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Fernando, A. D. Hoyos, R. J. Landreneau, S. Gilbert, W. E. Gooding, P. O. Buenaventura, N. A. Christie, C. Belani, and J. D. Luketich Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 639 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iizasa, M. Suzuki, K. Yasufuku, A. Iyoda, M. Otsuji, S. Yoshida, Y. Sekine, K. Shibuya, Y. Saitoh, K. Hiroshima, et al. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma Ann. Thorac. Surg., June 1, 2004; 77(6): 1896 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. V. Scagliotti, R. Fossati, V. Torri, L. Crino, G. Giaccone, G. Silvano, M. Martelli, M. Clerici, F. Cognetti, and M. Tonato Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer J Natl Cancer Inst, October 1, 2003; 95(19): 1453 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, W. Nishio, T. Sakamoto, H. Harada, K. Uchino, and N. Tsubota Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 558 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ichinose, K. Genka, T. Koike, H. Kato, Y. Watanabe, T. Mori, S. Iioka, A. Sakuma, and M. Ohta Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma J Natl Cancer Inst, April 16, 2003; 95(8): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kinch, M.-B. Moore, and D. H. Harpole Jr. Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival Clin. Cancer Res., February 1, 2003; 9(2): 613 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Colice, J. Rubins, and M. Unger Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy Chest, January 1, 2003; 123 (2009): 272S - 283S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Terzi, A. Lonardoni, G. Falezza, P. Scanagatta, A. Santo, G. Furlan, and F. Calabro Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jeremic, J. Classen, and M. Bamberg Regular follow{-}up for patients irradiated for early stage nonsmall{-}cell lung cancer too! Eur. Respir. J., January 1, 2002; 20(4): 1065 - 1066. [Full Text] [PDF]
|
|
|
|
|
|
M. Machtay, J. H. Lee, J. B. Shrager, L. R. Kaiser, and E. Glatstein Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma J. Clin. Oncol., October 1, 2001; 19(19): 3912 - 3917. [Abstract] [Full Text]
|
|
|
|
|
|
T. C. Mineo, V. Ambrogi, V. Corsaro, and M. Roselli Postoperative adjuvant therapy for stage IB non-small-cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Granone, L. Trodella, S. Margaritora, A. Cesario, G. M. Corbo, G. Mantini, M. Balducci, and G. Fumagalli Radiotherapy versus follow-up in the treatment of pathological stage Ia and Ib non-small cell lung cancer. Early stopped analysis of a randomized controlled study Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 418 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deslauriers and J. Gregoire Clinical and Surgical Staging of Non-Small Cell Lung Cancer Chest, April 1, 2000; 117 (2009): 96S - 103S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deslauriers and J. Gregoire Surgical Therapy of Early Non-Small Cell Lung Cancer Chest, April 1, 2000; 117 (2009): 104S - 109S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wagner Jr Postoperative Adjuvant Therapy for Patients With Resected Non-Small Cell Lung Cancer: Still Controversial After all These Years Chest, April 1, 2000; 117 (2009): 110S - 118S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Bunn Jr, J. Mault, and K. Kelly Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer : A Time for Reassessment? Chest, April 1, 2000; 117 (2009): 119S - 122S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pierard, P. Vermylen, T. Bosschaerts, C. Roufosse, T. Berghmans, J.-P. Sculier, and V. Ninane Synchronous Roentgenographically Occult Lung Carcinoma in Patients With Resectable Primary Lung Cancer Chest, March 1, 2000; 117(3): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blaes, M. Klotz, H. Huwer, U. Straub, G. Kalweit, K. Schimrigk, and H.-J. Schafers Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer Ann. Thorac. Surg., January 1, 2000; 69(1): 254 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujisawa, T. Iizasa, Y. Saitoh, Y. Sekine, S.-i. Motohashi, T. Yasukawa, K. Shibuya, K. Hiroshima, and H. Ohwada Smoking Before Surgery Predicts Poor Long-Term Survival in Patients With Stage I Non-Small-Cell Lung Carcinomas J. Clin. Oncol., July 1, 1999; 17(7): 2086 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. D'Amico, MD, M. Massey, MD, J. E. Herndon II, PhD, M.-B. Moore, and D. H. Harpole Jr A BIOLOGIC RISK MODEL FOR STAGE I LUNG CANCER: IMMUNOHISTOCHEMICAL ANALYSIS OF 408 PATIENTS WITH THE USE OF TEN MOLECULAR MARKERS J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 736 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Martini, V. W. Rusch, M. S. Bains, M. G. Kris, R. J. Downey, B. J. Flehinger, and R. J. Ginsberg FACTORS INFLUENCING TEN-YEAR SURVIVAL IN RESECTED STAGES I TO IIIA NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Landreneau, D. J. Sugarbaker, M. J. Mack, S. R. Hazelrigg, J. D. Luketich, L. Fetterman, M. J. Liptay, S. Bartley, T. M. Boley, R. J. Keenan, et al. WEDGE RESECTION VERSUS LOBECTOMY for STAGE I (T1 N0 M0) NON-SMALL-CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 691 - 700. [Abstract] [Full Text]
|
|
|
|
|
|
J. Padilla, V. Calvo, J. C. Penalver, G. Sales, and A. Morcillo Surgical Results and Prognostic Factors in Early Non-Small Cell Lung Cancer Ann. Thorac. Surg., February 1, 1997; 63(2): 324 - 326. [Abstract] [Full Text]
|
|
|
|
|
|
W.-W. Lai, M.-H. Wu, J.-J. Yan, and F.-F. Chen Immunohistochemical Analysis of nm23-H1 in Stage I Non-Small Cell Lung Cancer: A Useful Marker in Prediction of Metastases Ann. Thorac. Surg., November 1, 1996; 62(5): 1500 - 1504. [Abstract] [Full Text]
|
|
|
|
|
|
D. H. Harpole Jr, W. G. Richards, J. E. Herndon II, and D. J. Sugarbaker Angiogenesis and Molecular Biologic Substaging in Patients With Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., May 1, 1996; 61(5): 1470 - 1476. [Abstract] [Full Text]
|
|
|
|
|
|
Randomized Trial of Lobectomy Versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 1995; 60(3): 615 - 622. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Nesbitt, J. B. Putnam Jr, G. L. Walsh, J. A. Roth, and C. F. Mountain Survival in Early-Stage Non--Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 1995; 60(2): 466 - 472. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Izbicki, B. Passlick, O. Karg, C. Bloechle, K. Pantel, W. T. Knoefel, and O. Thetter Impact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer Ann. Thorac. Surg., January 1, 1995; 59(1): 209 - 214. [Abstract] [Full Text]
|
|
|
|
|
|
N. Martini, M. S. Bains, M. E. Burt, M. F. Zakowski, P. McCormack, V. W. Rusch, and R. J. Ginsberg Incidence of local recurrence and second primary tumors in resected stage I lung cancer J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 120 - 129. [Abstract] [Full Text]
|
|
|
|
|
|
W. H. Warren and L. P. Faber Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma:Five-year survival and patterns of intrathoracic recurrence J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1087 - 1094. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
